These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Arterial and venous thrombotic complications with thalidomide in multiple myeloma. Alkindi S; Dennison D; Pathare A Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975 [No Abstract] [Full Text] [Related]
23. Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus. Qian G; Liu T; Zhou C; Zhang Y J Dermatol; 2015 May; 42(5):539-40. PubMed ID: 25753523 [No Abstract] [Full Text] [Related]
24. Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial. Okon L; Rosenbach M; Krathen M; Rose M; Propert K; Okawa J; Werth V J Am Acad Dermatol; 2014 Mar; 70(3):583-4. PubMed ID: 24528907 [No Abstract] [Full Text] [Related]
25. Desensitization to thalidomide in a patient with multiple myeloma. Nucera E; Schiavino D; Hohaus S; Leone G; Buonomo A; Lombardo C; Patriarca G Clin Lymphoma Myeloma; 2008 Jun; 8(3):176-8. PubMed ID: 18650182 [TBL] [Abstract][Full Text] [Related]
26. Prurigo nodularis of Hyde treated with low-dose thalidomide. Orlando A; Renna S; Cottone M Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850 [TBL] [Abstract][Full Text] [Related]